Biosimilars, also called as follow-on biologics, are the approved biological products that are very similar to another biological drug manufactured by another company. They are cost-effective and help in prevention and treatment of different diseases like cancer, diabetes, autoimmune diseases, and infectious diseases, among others. The global biosimilars market is expected to witness stellar growth… Continue reading Key players in the Biosimilars Market focus on product launches and approvals